Core Viewpoint - The draft of the 2025 Restricted Stock Incentive Plan by Shandong Weigao Blood Purification Products Co., Ltd. aims to enhance corporate governance, attract and retain key talents, and align the interests of shareholders, the company, and core teams for long-term development. Group 1: Incentive Plan Overview - The plan proposes to grant 6.65 million restricted stocks, accounting for approximately 1.62% of the company's total share capital of 411.39 million shares as of the announcement date [2][11]. - The grant will be a one-time issuance with no reserved rights, and the total number of stocks involved in all effective equity incentive plans will not exceed 10% of the company's total share capital [2][11]. - The incentive objects include 124 individuals, such as directors, senior management, and core personnel, excluding independent directors and major shareholders [4][10]. Group 2: Grant Details - The grant price for the restricted stocks is set at 19.77 yuan per share, with adjustments possible based on corporate actions like stock dividends or capital increases [5][17]. - The effective period of the incentive plan is from the grant date until all restricted stocks are released from restrictions or repurchased, lasting no more than 48 months [3][6]. Group 3: Performance and Conditions - The plan includes performance assessment criteria based on the company's net profit growth, requiring a minimum growth rate of 10% for 2026, 21% for 2027, and 33% for 2028, using 2025's net profit as the baseline [19][21]. - The plan stipulates that if the company fails to meet the performance targets, the granted stocks will not be released from restrictions and will be repurchased by the company [18][20]. Group 4: Management and Approval Process - The shareholders' meeting is the highest authority for approving the plan, while the board of directors is responsible for its execution and management [7][28]. - The plan must be approved by a two-thirds majority of the voting rights at the shareholders' meeting, excluding votes from related parties [29].
威高血净: 山东威高血液净化制品股份有限公司2025年限制性股票激励计划(草案)